90 filings
Page 4 of 5
8-K
o7gqt7tqog5awx4n4ckg
4 Dec 13
Anthony D. Squeglia Appointed Chief Financial Officer
12:00am
8-K
6ca6dlq
15 Oct 13
Regulation FD Disclosure
12:00am
8-K
cq0w69zhss aum1u
4 Oct 13
Boston Therapeutics Closes $5.3 Million in Private Placement
12:00am
8-K
11ma53goke7izv7bq
16 Sep 13
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
w5bcepcwn2aw02u1msu
6 Sep 13
Entry into a Material Definitive Agreement
12:00am
8-K
tvm4v3iad7aszi
29 Jul 13
Entry into a Material Definitive Agreement
12:00am
8-K
o8wvq r3owqdual87s
6 Jun 13
Departure of Directors or Certain Officers
12:00am
8-K
x0nlnx4f2vyburm
14 Nov 12
Boston Therapeutics' Newly Appointed Chief Operating Officer Invests $625,000 in the Company's S-1 Financial Offering
12:00am
8-K
6gfzz9i7
13 Nov 12
Boston Therapeutics Names Jonathan B.Rome Chief Operating Officer
12:00am
8-K
56m fbr6c3xynw
10 Oct 12
Regulation FD Disclosure
12:00am
8-K
yqjh9 2awbarsh3x9g4
4 Oct 12
Other Events
12:00am
8-K
6gu3em 37vm5uh
14 Jun 12
Unregistered Sales of Equity Securities
12:00am
8-K
4qszklipdchvaps
7 Jun 12
Other Events
12:00am
8-K
zrux piln
27 Apr 12
Regulation FD Disclosure
12:00am
8-K
zcpwpzihsei
18 Apr 12
Other Events
12:00am
8-K
rea4teq
10 Apr 12
PAZ320 Tested at Dartmouth-Hitchcock Medical Center in New Hampshire
12:00am
8-K
rz1h2cjg8bwx
22 Mar 12
Other Events
12:00am
8-K
6yaw mlh5
2 Mar 12
Other Events
12:00am
8-K
fe2nkwcxiakbe9ljzwa1
24 Jan 12
Boston Therapeutics Announces Clinical Study Safety Results with SUGARDOWN® at University of Sydney
12:00am
8-K
nv7i0
29 Dec 11
Other Events
12:00am